Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Semaphorin 4D

Semaphorin 4D

Brief Information

Name:Semaphorin 4D
Target Synonym:SEMAJ,SEMA4D,Semaphorin 4D,Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) And Short Cytoplasmic Domain, (Semaphorin) 4D,C9orf164,CD100,BB18,GR3,A8,Sema Domain, Immunoglobulin Domain (Ig), Transmembrane Domain (TM) And Short Cytoplasmic Domain, 4D,Chromosome 9 Open Reading Frame 164,CD100 Antigen,M-Sema-G,M-Sema G,Coll-4,COLL4,FLJ39737,Semaphorin-4D
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 2 Clinical

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CD0-H5257 Human Human Semaphorin 4D / SEMA4D / CD100 Protein, Fc Tag
ACRO Quality

Part of Bioactivity data

 Semaphorin 4D ELISA

Immobilized Human Plexin B2, His Tag (Cat. No. PL2-H52H3) at 5 μg/mL (100 μL/well) can bind Human SEMA4D, Fc Tag (Cat. No. CD0-H5257) with a linear range of 0.039-1.25 μg/mL (Routinely tested).

Synonym Name



Cluster of Differentiation 100 (CD100) is also known as Semaphorin-4D (SEMA4D), is a single-pass type I membrane protein which belongs to the

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Pepinemab VX-15; VX-15/2503; moAb VX-15/2503 Phase 2 Clinical Vaccinex Inc Solid tumours; Squamous Cell Carcinoma of Head and Neck; Colonic Neoplasms; Pancreatic Neoplasms; Multiple Sclerosis; Osteosarcoma; Huntington Disease; Breast Neoplasms; Colorectal Neoplasms; Alzheimer Disease; Melanoma; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
+1 888-377-6111
1 Innovation Way, Newark, DE 19711, USA

Leave a message